Jagsonpal Pharmaceuticals to acquire Group Pharmaceuticals' wellness portfolio

Jagsonpal Pharmaceuticals has signed a business transfer agreement to acquire the wellness portfolio of Group Pharmaceuticals via a slump sale.

Editor's note: The draft correctly summarizes the business transfer agreement details.

This article is AI-generated and fact-gated. Original reporting: BS Personal Finance